MITSI PIMENTEL: Open Payments
NPI 1972040798 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 60 payments from 15 companies in 2025. Trend: 2023 $1,351 · 2024 $1,330 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $428 |
| Novo Nordisk Inc | 15 | $256 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $143 |
| Dexcom, Inc. | 5 | $82 |
| Astellas Pharma US Inc | 3 | $64 |
| Exact Sciences Corporation | 3 | $43 |
| Lilly USA, LLC | 2 | $36 |
| ABBVIE INC. | 1 | $23 |
| Dynavax Technologies Corporation | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: Ozempic, TRELEGY ELLIPTA, JARDIANCE, PENMENVY, AREXVY, Dexcom G6 Transmitter, Veozah, SHINGRIX.
Industry payments across TX — which companies pay providers there.
